Microbiology News : clinical, Dec 2021

SARS-CoV-2 Mutants Protein Available at Creative Diagnostics
Creative Diagnostics has launched a range of SARS-CoV-2 recombinant antigens that can be used to test the efficacy of COVID-19 vaccines, SARS-CoV-2 antibodies and rapid antigen testing. more...
nanoComposix Lateral Flow Assay development services
In this podcast, Andre Alfaro, Director of Assay Development at nanoComposix, lends expertise to medical device manufacturers entering the LFT market, particularly for COVID-19. Andre provides insights into this fast-growing sector and explains how nanoComposix can help every step of the way. more...
SeptiCyte The First One-Hour Direct-from-Blood Sepsis Test
Fully automated diagnostic tool SeptiCyte® RAPID quantifies the relative expression levels of genes involved in a patient's immune response to infection to aid in a diagnosis in one hour for patients suspected of sepsis. more...

Pharmig's 29th Annual Conference - A rapidmicrobiology Report

10 Dec 2021 | ClinicalPharmaceuticalCosmetic/Personal Care

Pharmaceutical Microbiology interest Group conference report
Highlights from this year's Pharmig Annual Conference. Now in its 29th year, the conference facilitates the discussion on hot topics in the pharma, healthcare, and personal care and cosmetic industries.  more...
Alpha Laboratories partnered with the Clinical Biochemistry team at Cwm Taf Morgannwg University Health Board to implement the quantitative Faecal Immunnochemical Test (FIT) which helps identify patients who may have significant colorectal disease. more...
FluoroType SARS-CoV-2 varID Q PCR Assay
Bruker Corporation has announced that its established CE-IVD marked FluoroType® SARS-CoV-2 varID Q real-time multiplexed PCR assay reliably detects all SARS-CoV-2 variants. more...
SARS-CoV-2 Pseudovirus Neutralization Assay
Creative Diagnostics has developed a SARS-CoV-2 pseudovirus with HIV lentiviral vector that meets the requirements for SARS-CoV-2 neutralization assays and screening neutralization antibodies or serum. more...
Sino Biological
Sino Biological, Inc. has launched a panel of research reagents for the newly identified Omicron which has quickly raised concerns around the world because of the high number of mutations it carries, especially the 30-plus mutations on the Spike protein. more...
Omicron variant RBD and Spike proteins
The nucleocapsid protein is commonly used as the biomarker in rapid antigen tests. It’s critical to assess whether the current commercial antigen tests can detect the mutated N proteins with the same sensitivity and specificity as their WT counterpart. more...
Integra Pipettes
INTEGRA Biosciences supplies a comprehensive range of liquid handling tools that are ideal for sterile cell biology workflows. Each piece of equipment has been expertly designed to fit comfortably under a laminar flow hood to reduce the risk of cell culture contamination. more...